Maxime M. A. Verhoeven

Author

Also Known As

M. M. A. Verhoeven, M. Verhoeven, Maxime M A Verhoeven, Maxime M. A. Verhoeven, Maxime M.A. Verhoeven, Maxime MA Verhoeven, Maxime Verhoeven

Publications

338

Citations

H-Index

Concepts

All Affiliations

Maxime M. A. Verhoeven is an author at University Medical Center Utrecht.

Maxime M. A. Verhoeven

Publications

Citations

H-Index

Page 1

	Year	Citations
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis Helen R. Gosselt, Maxime M. A. Verhoeven, M Bulatović-Ćalasan, Journal of Personalized Medicine	2021	35
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials Maxime M. A. Verhoeven, Marjolein JH de Hair, Janneke Tekstra, Annals of the Rheumatic Diseases	2019	19
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio Helen R. Gosselt, Maxime M. A. Verhoeven, Maurits C. F. J. de Rotte, Rheumatology and Therapy	2020	13
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including <scp>HandScan</scp> (Optical Spectral Transmission) Scores Maxime M. A. Verhoeven, A. A. A. Westgeest, Andreas Schwarting, Arthritis Care & Research	2021	12
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis Maxime M. A. Verhoeven, Janneke Tekstra, Jacob M. van Laar, The Journal of Rheumatology	2020	11

Page 1